Fever with a spreading rash, confusion, or trouble breathing after a tick bite needs emergency care. Call 911.
Besides Lyme, testing covers ehrlichiosis, anaplasmosis, babesiosis, spotted fever rickettsiosis (including Rocky Mountain spotted fever) and a smaller group of tick-borne viruses. These are different organisms living in different places in the blood, and no single test finds all of them.
Ehrlichiosis and anaplasmosis are caused by bacteria that live inside white blood cells. Babesiosis is caused by a parasite that lives inside red blood cells, behaving more like a malaria parasite than a bacterium. Rocky Mountain spotted fever is caused by a rickettsial bacterium that injures the lining of small blood vessels, which is why the illness can involve rash, low blood pressure and organ strain. Tick-borne viruses are a separate group again, with their own laboratory approach.
An update on North American tick-borne diseases describes how the preferred method of diagnosis changes by organism, with direct detection suited to some infections and antibody testing suited to others 1. Research suggests that recognition of tick-borne viruses is increasing globally and that their diagnosis relies on laboratory approaches distinct from those used for bacterial tick-borne infections 2.
The practical meaning is simple. Asking for a tick panel is not one decision, it is several. What gets ordered depends on the symptoms, the exposure, and how many days the person has been unwell. A clinician makes that call, and the ordering choice matters as much as the laboratory running it.
Timing changes everything because the two families of tests measure two different things. Direct tests look for the organism itself while it is circulating, which is usually during the first days of fever. Antibody tests look for the immune response, which takes time to build and can lag behind how sick someone feels.
That lag is the single most common reason a result confuses people. Someone feels terrible on day three, the antibody test comes back negative, and it reads like reassurance. It is not reassurance. It is a measurement taken before the thing being measured exists in detectable amounts.
Studies indicate that antibody results in rickettsial illness are often negative during the first week of symptoms, which is why samples are taken in the acute phase and again during convalescence so that a rise in antibody level can be compared 3. Evaluations of laboratory methods on clinical patient samples suggest that performance differs widely between methods, between infections and according to how long someone has been ill 4.
So the useful question is never only which test, it is which test on which day. In the first week, direct detection tends to carry more weight. After the first week or two, antibody comparison tends to carry more weight. A result that arrives without its date attached is hard to read, so note the day symptoms began and keep it with the paperwork.
PCR detects the genetic material of the organism in a blood sample, so it is most useful early, while the organism is still circulating and before treatment from a clinician has begun. It answers a direct question. Is this pathogen present in this tube of blood right now.
Because PCR looks for the organism rather than the immune response, it can be positive on the first day of fever, long before any antibody appears. That early window is exactly when a clinician most wants information, and it is why a blood draw taken while someone is acutely febrile is more informative than one taken after symptoms settle.
Methods for detecting tick-borne pathogens have broadened considerably, including approaches that look for several organisms from a single sample 5. For human granulocytic anaplasmosis, amplification-based detection on blood taken during the acute phase has been described as a central part of confirming the infection 6.
PCR has limits worth knowing. If the organism has already been cleared, or if the sample is drawn after the acute phase has passed, a negative result does not settle the question. Sample handling and the specific target the laboratory uses also matter. A negative PCR in someone who is genuinely unwell is a reason to keep looking, not a reason to stop.
A blood smear adds direct visual confirmation. A drop of blood is spread on a slide, stained, and examined under a microscope by a trained reader looking for the organism inside the blood cells themselves.
In babesiosis, the parasite can be seen inside red blood cells, and examination of a stained smear is one of the recognised ways the infection is identified alongside amplification testing 7. In ehrlichiosis and anaplasmosis, clusters of bacteria called morulae can sometimes be seen inside white blood cells, a finding described as supportive when present 6.
The catch is sensitivity. When very few cells are infected, a smear can be read as negative even though the infection is there. The result also depends on the skill and time of the person at the microscope, and on the smear being prepared properly from a fresh sample. Laboratory descriptions of tick-borne disease note that routine blood findings and microscopy are read together rather than in isolation 8.
What that means for a reader holding a result. A positive smear is strong information. A negative smear early in an illness is weak information, and it does not close the case on its own.
Antibody tests measure the immune response to an organism rather than the organism itself, so they turn positive only after the immune system has had time to respond. That delay is normal biology, not laboratory error.
Two patterns are usually described. IgM antibodies tend to appear first and fade, while IgG antibodies appear later and can persist for a long time after the infection has resolved. That persistence is why a single positive IgG, by itself, does not tell anyone whether an infection is current or historical. The comparison that carries more weight is a significant rise between a sample taken while acutely ill and a second sample taken weeks later, the paired approach used in rickettsial illness 3.
Cross-reaction is the other complication. Related organisms can share antigens, so an antibody signal may point to a family of infections rather than one precise member of it. Evaluations of serological methods on patient samples suggest that how well a test performs depends on the assay chosen and on the stage of illness when the sample was drawn 4.
So an antibody result is read as a shape over time, not a single yes or no. One early negative plus one later rise tells a clearer story than either number alone. A clinician interprets that pattern against symptoms and exposure.
A platelet count measures the number of platelets, the small cell fragments that form the first plug at a site of bleeding, in a volume of blood. It is reported on a standard complete blood count, so most people already have one on file from routine bloodwork.
It matters here because platelet counts can drop during several acute tick-borne infections, which makes the number a useful early signal rather than a diagnosis. A low result is an observation that prompts further questions about exposure, fever and other blood findings.
For what the marker is, how it is measured, what moves it, and how to read a high or low result in full, see the Platelets guide. The rest of this page stays on testing for tick-borne infection itself.
Three routine findings come up repeatedly after a tick bite. A falling platelet count, a reduced white blood cell count, and raised liver enzymes. None of them names an organism, and none of them is specific, but together they shift a vague febrile illness into a pattern worth investigating.
Studies indicate that a low platelet count is associated with acute human granulocytic ehrlichiosis and with babesiosis, alongside other routine laboratory changes seen during these illnesses 8. Guidance on babesiosis describes laboratory findings that accompany the infection and are read together with direct detection of the parasite 7.
| Marker | Lab reference range | FitScript optimal range |
|---|---|---|
| Platelets | As printed on your lab report | 150 to 300 K/µL |
Compare your result with the range printed on your lab report. Ranges vary by laboratory, age and sex. FitScript's optimal range is an optimization target, not a diagnostic cut-off.
Other markers are reported in words rather than numbers here, because their ranges differ too much between laboratories to be useful on a page. Liver enzymes such as ALT and AST may run above the laboratory's stated range during acute infection. Inflammatory markers such as CRP often rise with any significant infection and say nothing about which one. A white cell count may fall rather than rise, which surprises people who expect every infection to push it up.
The sequence to hold onto is observation, then possible meaning, then next step. A platelet count that has dropped below the standard range in someone with fever after a tick bite is an observation. It may reflect an acute infection, or several other things entirely. The next step is a conversation with a clinician while the result is still fresh, not a self-made conclusion.
A clinician may begin treatment before confirmation arrives because the window in which early treatment matters most can close before the laboratory can answer. This is a recognised feature of these illnesses, not a shortcut.
The reason sits in the timing problem described above. Antibody testing in rickettsial illness is frequently negative during the first week of symptoms, so waiting for a confirmatory antibody result means waiting past the period when someone is becoming sicker 3. Direct detection helps, but samples still need collecting, transporting and running.
So a clinician weighs the clinical picture, the season, the exposure history and the routine blood findings, and makes a judgement. Treatment decisions belong to a licensed provider, who evaluates whether any treatment is appropriate for that person. Some medicines can also influence blood results and how an illness behaves, so ask your prescriber about anything already being taken.
For a reader, the useful behaviour is practical. Get the blood drawn before anything starts if that is possible, because an early sample preserves the chance of direct detection. Then follow the clinician's instructions rather than waiting for a number to arrive. A negative test that lands three days later does not retroactively make someone well, and a positive one does not change what should have happened on day one.
Babesiosis is tested by looking directly for the parasite, either on a stained blood smear or by amplification of its genetic material from blood. Professional guidance on babesiosis describes diagnosis resting on identification of the parasite in blood rather than on antibody testing alone 7.
On a smear, the parasite is seen inside red blood cells. The proportion of infected cells can be estimated, which gives a sense of how heavy the infection is and is tracked over time by the clinician managing it. When very few cells are infected, microscopy can miss it, and amplification testing is more sensitive in that situation.
Antibody testing has a supporting role. It can show that an immune response has occurred, but because antibodies persist, a positive result does not separate a current infection from a past one. That is the same persistence problem described earlier for other tick-borne infections.
Routine bloodwork often accompanies the picture, including a low platelet count and changes in red blood cell measures 8. Adults without a functioning spleen, older adults, and people with weakened immune function are described in professional guidance as having a more serious course, which is one reason a clinician asks about medical history before deciding what to order and how closely to follow it 7.
Ehrlichiosis and anaplasmosis are tested with amplification of bacterial genetic material from blood during the acute phase, supported by microscopy and, later, by antibody comparison. Amplification testing on acute-phase blood has been described as a central tool for confirming human granulocytic anaplasmosis 6.
Microscopy can contribute when morulae, the small clusters of bacteria inside white blood cells, are visible. When present, they are informative. When absent, they rule out nothing, because they are seen in only a share of cases and depend on the reader and the timing of the smear 6.
Antibody testing comes later and works best as a paired comparison between acute and convalescent samples, for the same reason it does in other tick-borne infections.
The routine bloodwork pattern is often what raises the question in the first place. Low platelets, a low white cell count and raised liver enzymes appear together often enough in these infections to be a recognised laboratory signature 8. A current review of North American tick-borne disease diagnosis sets out how direct detection and antibody methods are sequenced for these organisms 1.
One more practical note. Fever without a rash is common in these infections, so the absence of a rash is not a reason to dismiss an exposure.
Rocky Mountain spotted fever is confirmed mainly by comparing antibody levels in paired samples, which means confirmation usually arrives after the decisions about care have already been made. Descriptions of diagnostic testing for rickettsial disease set out this paired acute and convalescent approach, along with the frequent negativity of a single early sample 3.
When a rash is present, examination of a small skin sample from the rash using staining that targets the organism has been described as a way of identifying rickettsiae directly, offering information earlier than antibody comparison can 3. Whether that is appropriate is a clinician's decision, and it is not available everywhere.
Amplification-based detection has a role as well, and current diagnostic guidance for North American tick-borne disease describes how these methods fit together for spotted fever group infections 1.
Routine results can support the suspicion. A falling platelet count, low sodium and raised liver enzymes are among the findings that can accompany this illness, and they are read together with the clinical picture rather than alone.
This is the infection behind the urgent line at the top of the page. A spreading rash with fever, confusion, or difficulty breathing after a tick bite is a reason for emergency care, not a reason to wait for a laboratory report.
Tick-borne viruses are tested differently again, usually by detecting viral genetic material during the acute phase or by looking for a specific antibody response, and the testing is not part of a routine bacterial workup. Research suggests that these viral infections are being recognised more widely, with diagnostic strategies that differ from those used for bacterial tick-borne infections 2.
That difference matters in practice. A negative bacterial workup does not address a viral cause at all, because the tests were never aimed at it. Access to viral testing varies, and some of it runs through public health laboratories rather than commercial ones, so a clinician may need to request it specifically.
Detection methods for tick-borne pathogens in general have expanded, including multiplexed approaches that look for more than one organism from a single sample 5. Those broader methods are useful precisely because exposure to a tick is not exposure to one organism.
The reader's takeaway is modest but useful. If symptoms after a tick bite are significant and the first round of testing comes back unremarkable, that is worth raising again with the clinician rather than filing away. Which further tests make sense is a clinical judgement based on symptoms, exposure and timing.
Some laboratories offer testing of a removed tick for the organisms it may carry, but a result from the tick is information about the tick, not a diagnosis of the person. It cannot confirm that transmission occurred, and it cannot confirm that it did not.
The reason is that transmission depends on more than presence. How long the tick was attached, how it was removed, and the biology of the specific organism all affect whether anything crossed over. A positive tick result in a person with no symptoms does not establish infection, and a negative tick result in someone who then develops fever does not settle anything either.
Methods for detecting tick-borne pathogens have broadened in recent years, including approaches applied to ticks as well as to human samples 5.
Where a tick result can genuinely help is as context. If the tick is kept in a sealed bag with the date of removal noted, that record supports the clinical conversation whatever the laboratory does with it. Species and attachment time are usually more useful to a clinician than any organism result from the tick itself. The decision about what to do next is still made from the person's symptoms and their own blood results.
A negative result rules out less than most people assume, and how much less depends almost entirely on which test was run and on which day. This is the most common misreading of tick-borne illness testing.
A negative antibody test taken in the first week of symptoms mostly reflects that antibodies have not yet developed 3. A negative amplification test taken after the acute phase mostly reflects that the organism is no longer circulating in detectable amounts. Neither is a clean all-clear, because both were asking a question outside their best window.
Evaluations of laboratory methods on patient samples suggest that sensitivity and specificity vary substantially by method, by organism and by sampling time, which is why results are interpreted against the clinical picture rather than as standalone verdicts 4. Current diagnostic guidance for North American tick-borne disease similarly presents testing as a sequence matched to the stage of illness 1.
So what does a negative result justify. It justifies lowering the probability of that one organism, at that one moment, by that one method. It does not justify ignoring ongoing symptoms, and it never justifies dismissing an abnormal routine result that came with it. If someone remains unwell after a negative workup, that is a reason to go back to the clinician, not a reason to accept the result as the end of the matter.
It is worth talking to a clinician whenever fever, severe headache, muscle aches, a new rash or unexplained exhaustion follow a known or possible tick exposure, and it is worth doing it early rather than waiting to see whether things settle. Early contact preserves the chance of direct detection, which fades as the acute phase passes.
It is also worth a conversation when routine bloodwork comes back with a platelet count below the standard range, raised liver enzymes, or a reduced white cell count in the weeks after an outdoor exposure. Those are suboptimal results rather than answers, and the useful move is to bring them to a clinician with the date of the exposure and the date symptoms began. Never set an abnormal result aside because a single test came back negative.
Bring four things to the appointment. The date of the bite or exposure if known, the date symptoms started, any ticks kept after removal, and a copy of recent bloodwork. Those four details narrow the testing question faster than symptoms alone.
FitScript's membership includes 150+ biomarkers tested per year with interpretation from Atlas, its AI health advisor, which makes a baseline platelet count and liver panel available for comparison when something changes. Discuss any result or treatment question with a clinician or licensed provider, who decides what is appropriate for you. This page is educational and not medical advice.
Related reading on FitScript covers tick bite symptoms and what to watch for after a bite, the lyme disease test and how its results are read, and how long does fatigue last after illness for recovery that drags on.
Testing can cover ehrlichiosis, anaplasmosis, babesiosis, spotted fever rickettsiosis including Rocky Mountain spotted fever, and a smaller group of tick-borne viruses. Each organism has its own preferred test, so there is no single panel that answers every question. A clinician decides which tests to order based on symptoms, exposure and how long the person has been unwell.
If symptoms such as fever, severe headache or a new rash appear, contact a clinician straight away rather than waiting. Blood drawn during the first days of fever preserves the chance of finding the organism directly, which becomes harder later. Testing a person with no symptoms right after a bite usually tells you very little.
Antibody tests measure the immune response, and that response takes time to build, so an early sample can read negative while the infection is active. Direct tests have the opposite problem and work best early, before the organism clears from the blood. The day the sample was taken is as important as the result itself.
A platelet count below the standard range is a clue, not a diagnosis, and it can have many causes unrelated to ticks. Combined with fever and a recent exposure, it is a reason to raise the question with a clinician promptly rather than to wait and watch. Bring the lab report and the date your symptoms started.
Keeping it in a sealed bag with the removal date noted is reasonable, because the species and how long it was attached can help a clinician. A laboratory result from the tick itself is information about the tick, not about you, and it cannot confirm or exclude infection in a person. Decisions still rest on your symptoms and your own blood results.
Often yes, since several tests can be run from the same collection, though not every method is available at every laboratory. What matters more is that the right tests are chosen for the stage of illness. Ask the ordering clinician which infections are being covered and which are not.
Not always. When someone is clearly unwell after a tick exposure, a clinician may begin care before confirmation arrives, because the window when early care matters most can close before a laboratory can answer. Treatment decisions belong to a licensed provider who evaluates the individual.
Recovery varies a great deal between people and between infections, and feeling flat for a while after an acute illness is common. Fatigue that drags on for weeks, or that comes with fever, breathlessness or new symptoms, is worth raising with a clinician. Repeat bloodwork can help show whether earlier abnormal results have settled.